Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Hashimoto

Showing results (551-560 of 862) with videos related to

Pageof 87
Sort By:
Molecular Psychiatry|February 6, 2026
Neuropsychiatric drug development in China: Current status and emerging trendsJingyao Huang, Chaoli Huang, Yawei Ji, et al.
The Journal of Nutritional Biochemistry|February 24, 2026
Dietary sulforaphane glucosinolate alleviates stress-induced depression and demyelination through gut-brain axis modulationDan Xu, Akifumi Eguchi, Rumi Murayama, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 26, 2026
Antibiotic-induced Microbiome Depletion Selectively Reduces Baseline Hypothalamic Oxytocin Signaling without Affecting MDMA-induced Oxytocin Response in RatsYong Yue, Yi Cai, Rumi Murayama, et al.
Neurobiology of Disease|June 1, 2022
Corrigendum to "(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut-microbiota-brain axis" [Neurobiol Dis. 165 (2022):105635.]Xingming Wang, Lijia Chang, Xiayun Wan, et al.
Pharmacology, Biochemistry, and Behavior|March 12, 2020
Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamineZhongwei Xiong, Lijia Chang, Youge Qu, et al.
Pharmacology, Biochemistry, and Behavior|June 21, 2020
Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor MT-3014 in ratsMisae Takakuwa, Yumi Watanabe, Takeaki Saijo, et al.
JAMA Network Open|December 1, 2022
Effect of Intraoperative Esketamine Infusion on Postoperative Sleep Disturbance After Gynecological Laparoscopy: A Randomized Clinical TrialDi Qiu, Xing-Ming Wang, Jin-Jin Yang, et al.
Brain Research|November 8, 2003
Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortexNaoe Okamura, Kenji Hashimoto, Eiji Shimizu, et al.
The International Journal of Neuropsychopharmacology|June 13, 2018
No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation ModelLijia Chang, Hidetoh Toki, Youge Qu, et al.
SAGE Open Medical Case Reports|August 25, 2017
A case with a large intracoronary mobile mass diagnosed with a calcified thrombus using optical frequency domain imaging and intravascular ultrasoundToshiki Kuno, Kenji Hashimoto, Syohei Imaeda, et al.
Pageof 87

Showing results (551-560 of 862) with videos related to

Sort By:
Pageof 87
Molecular Psychiatry|February 6, 2026
Neuropsychiatric drug development in China: Current status and emerging trendsJingyao Huang, Chaoli Huang, Yawei Ji, et al.
The Journal of Nutritional Biochemistry|February 24, 2026
Dietary sulforaphane glucosinolate alleviates stress-induced depression and demyelination through gut-brain axis modulationDan Xu, Akifumi Eguchi, Rumi Murayama, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 26, 2026
Antibiotic-induced Microbiome Depletion Selectively Reduces Baseline Hypothalamic Oxytocin Signaling without Affecting MDMA-induced Oxytocin Response in RatsYong Yue, Yi Cai, Rumi Murayama, et al.
Neurobiology of Disease|June 1, 2022
Corrigendum to "(R)-ketamine ameliorates demyelination and facilitates remyelination in cuprizone-treated mice: A role of gut-microbiota-brain axis" [Neurobiol Dis. 165 (2022):105635.]Xingming Wang, Lijia Chang, Xiayun Wan, et al.
Pharmacology, Biochemistry, and Behavior|March 12, 2020
Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamineZhongwei Xiong, Lijia Chang, Youge Qu, et al.
Pharmacology, Biochemistry, and Behavior|June 21, 2020
Antipsychotic-like effects of a novel phosphodiesterase 10A inhibitor MT-3014 in ratsMisae Takakuwa, Yumi Watanabe, Takeaki Saijo, et al.
JAMA Network Open|December 1, 2022
Effect of Intraoperative Esketamine Infusion on Postoperative Sleep Disturbance After Gynecological Laparoscopy: A Randomized Clinical TrialDi Qiu, Xing-Ming Wang, Jin-Jin Yang, et al.
Brain Research|November 8, 2003
Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortexNaoe Okamura, Kenji Hashimoto, Eiji Shimizu, et al.
The International Journal of Neuropsychopharmacology|June 13, 2018
No Sex-Specific Differences in the Acute Antidepressant Actions of (R)-Ketamine in an Inflammation ModelLijia Chang, Hidetoh Toki, Youge Qu, et al.
SAGE Open Medical Case Reports|August 25, 2017
A case with a large intracoronary mobile mass diagnosed with a calcified thrombus using optical frequency domain imaging and intravascular ultrasoundToshiki Kuno, Kenji Hashimoto, Syohei Imaeda, et al.
Pageof 87